Compound details
Wattoside G
| Compound ID | CDAMM01241 |
|---|---|
| Common name | Wattoside G | IUPAC name | 5\',7,9,13-tetramethyl-17-(3,4,5-trihydroxyoxan-2-yl)oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2\'-oxane]-14,15,16,18-tetrol |
| Molecular formula | C32H52O11 |
| Retention time | 0.3 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 613.362 | Theoretical mz | 613.358 |
| Error | 5.75 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.6741 |
| Inchi key | ORXKAXSJMZSRAH-UKVHCALONA-N |
|---|---|
| Smiles | OC1COC(OC2C(O)C(O)C(O)C3(C)C4CCC5(C)C(CC6OC7(OCC(C)CC7)C(C)C65)C4CCC23O)C(O)C1O |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | T18477 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SwissTargetPrediction |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SwissTargetPrediction |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SwissTargetPrediction |
| Q9Y251 | HPSE | Heparanase | T47623 | SwissTargetPrediction |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T18477 | DI0015 | Acute upper respiratory infection | [ICD-11: CA07] | P07900 | HSP90AA1 |
| T18477 | DI0037 | Asthma | [ICD-11: CA23] | P07900 | HSP90AA1 |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T47623 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | Q9Y251 | HPSE |
| T47623 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q9Y251 | HPSE |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |